Abha Kundi’s Insights

27 total results. Page 1 of 3.

Alerts
Gene Editing for Human Therapies Just Got a Shortcut: What the FDA’s New Draft Guidance Means for Your Business
Alerts
Pay(or) Attention, Drug and Device Makers: FDA’s New Guidance for Talking to Health Plans
News
Brain Computer Interfaces Boot Up Multipronged Legal Issues
Alerts
AI Do: Why the FDA Wants Your Input on AI in Clinical Trials (and Why You Should Give It)
Events
Webinar: From Serial Numbers to Supply Chain Security
Longevity Lens
The Shot Heard ‘Round the Pharmacy’: FDA Takes Aim at GLP-1 Compounders
Longevity Lens
The Amino-zing World of Peptide Regulation
Alerts
All Filler, No Foundation: Pure Indulgence’s 483 Becomes a DSCSA Warning Letter
Longevity Lens
The Brain-Computer Interface Race Is On – Is the Law Ready?
Events
2026 Chicago Pharma Forum
Alerts
Navigating the 2026 Life Sciences Legal Landscape
Alerts
NDSee You in 2033: FDA’s 12‑Digit NDC Is Coming